Jefferies Financial Group’s GSK GSK Stock Holding History

Jefferies Financial Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-40,000	Closed	-$1.41M	–	1756
2022 Q4	$1.41M	Buy	+40,000	New	+$1.33M	0.01%	775

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jefferies Financial Group's GSK Position: Q1 2026 in Review

Jefferies Financial Group sold out of GSK (GSK) in Q1 2026, closing a stake of 13,825 shares — an estimated $678K sold.

Jefferies Financial Group first reported a position in GSK in Q4 2022 and held it in 3 quarters. The position peaked at $852K in Q3 2023. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Jefferies Financial Group reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
Jefferies Financial Group sold 13,825 GSK shares in Q1 2026, an estimated $678K.
Jefferies Financial Group first reported a position in GSK in Q4 2022 and held it in 3 quarters.
Jefferies Financial Group's GSK position peaked at $852K in Q3 2023.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.